Multimodal imaging of bilateral diffuse uveal melanocytic proliferation associated with an iris mass lesion

por Naysan, Jonathan, Pang, Claudine E., Klein, Robert W., Freund, K. Bailey
Publicado 2016

Cost-Effectiveness of Tamsulosin, Doxazosin, and Terazosin in the Treatment of Benign Prostatic Hyperplasia

por Ohsfeldt, Robert L., Kreder, Karl J., Klein, Robert W., Chrischilles, Elizabeth A.
Publicado 2004

The cost effectiveness of teriparatide as a first-line treatment for glucocorticoid-induced and postmenopausal osteoporosis patients in Sweden

por Murphy, Daniel R, Smolen, Lee J, Klein, Timothy M, Klein, Robert W
Publicado 2012

Estimated economic benefits from low-frequency administration of atypical antipsychotics in treatment of schizophrenia: a decision model

por Furiak, Nicolas M, Gahn, James C, Klein, Robert W, Camper, Stephen B, Summers, Kent H
Publicado 2012

Modeling screening, prevention, and delaying of Alzheimer's disease: an early-stage decision analytic model

por Furiak, Nicolas M, Klein, Robert W, Kahle-Wrobleski, Kristin, Siemers, Eric R, Sarpong, Eric, Klein, Timothy M
Publicado 2010

The Budget Impact of Including Necitumumab on the Formulary for First-Line Treatment of Metastatic Squamous Non-Small Cell Lung Cancer: U.S. Commercial Payer and Medicare Perspecti...

por Bly, Christopher A., Molife, Cliff, Brown, Jacqueline, Tawney, Mahesh K., Carter, Gebra Cuyun, Cinfio, Frank N., Klein, Robert W.
Publicado 2018

Cost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the United States

por Furiak, Nicolas M, Ascher-Svanum, Haya, Klein, Robert W, Smolen, Lee J, Lawson, Anthony H, Conley, Robert R, Culler, Steven D
Publicado 2009

Estimated Budget Impact of Increased Use of Mirabegron, A Novel Treatment for Overactive Bladder

por Perk, Sinem, Wielage, Ronald C., Campbell, Noll L., Klein, Timothy M., Perkins, Anthony, Posta, Linda M., Yuran, Thomas, Klein, Robert W., Ng, Daniel B.
Publicado 2016